English
|
ÖÐÎÄ
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Gongdong Medical 's half-year net profit of CNY 211 million, up 18.92% year-on-year
2022-08-24
Gongdong Medical recently released its 2022 semi-annual report, in which the company achieved operating revenue of CNY 799 million, an increase of 38.70% year-on-year; net profit attributable to shareholders of the listed company was CNY 211 million, an increase of 18.92% year-on-year.
Harvard University, Wyss Institute License Protein Detection Technology to Spear Bio
2022-08-24
The Wyss Institute and Harvard University said on Tuesday that they have licensed protein detection technology to Spear Bio.
Merck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant Therapy
2022-08-24
Merck, known as MSD outside the United States and Canada, today announced that the U.S. FDA has granted Fast Track designation for Merck¡¯s investigational anticoagulant therapy MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease.
Sansure Biotech's monkeypox nucleic acid detection kit was certified by the British MHRA
2022-08-23
Recently, the monkeypox virus nucleic acid detection kit (PCR-fluorescent probe method) independently developed by Sansure Biotech has passed the British MHRA certification. This is another authoritative certification obtained after the EU CE.
Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay
2022-08-23
Pillar Biosciences said Monday that China's National Medical Products Administration has granted commercial approval for its OncoReveal Dx Colon Cancer Assay.
Biden administration will stop buying Covid-19 vaccines, treatments and tests as early as this fall, Jha says
2022-08-23
The Biden administration has been planning for how to get past the crisis phase of the Covid-19 pandemic and will stop buying vaccines, treatments and tests as early as this fall, White House Covid-19 Response Coordinator Dr. Ashish Jha said on Tuesday.
Shanghai United Imaging Healthcare officially landed on the Science and Technology Innovation Board in China
2022-08-22
According to reports, Shanghai United Imaging Healthcare Co., Ltd was officially listed on the Science and Technology Innovation Board on August 22 with the stock code "688271".
High-Throughput Testing Reveals Genetic Programs, Pathogenic Variants in Neurodegenerative Disease
2022-08-22
Researchers at the University of California, Los Angeles have identified noncoding genetic regulatory elements that impact the risk of dementia from Alzheimer's disease and the pathologically related progressive supranuclear palsy (PSP).
New blood screening solution Cobas ® MPX launched by Roche Diagnostics in China
2022-08-19
As an important medical resource to save lives, blood safety is very important and blood screening is the most critical link to ensure blood safety.
Autism Spectrum Disorder Studies Uncover Additional Genetic Risk Variants
2022-08-19
A pair of new studies examines genetic variations that confer risk of developing autism spectrum disorder, providing insight into the different phenotypes associated with the disorder.
CorDx Gets CE-IVD Marks for Monkeypox Assays
2022-08-19
San Diego-based diagnostics firm CorDx said on Thursday that it has obtained CE-IVD marks for a PCR test and a lateral flow test for monkeypox.
AutoBio achieved 29.28% increase in the first half of the year
2022-08-18
On August 17, AutoBio Diagnostics released its first-half results of 2022. The company achieved CNY 2.070 billion revenue by the end of June, with a year-on-year increase of 23.41%. The net profit attributable to shareholders was CNY 534 million, increasing 29.28% than the last year.
Eurobio Scientific to Acquire GenDx for €135M in Cash
2022-08-18
French diagnostics firm Eurobio Scientific said on Wednesday that it has agreed to acquire Genome Diagnostics, also known as GenDx, for €135 million ($137.2 million) in cash.
Agilent Fiscal Q3 Revenues up 8 Percent, Beat Analyst Estimate
2022-08-18
Agilent Technologies announced after the close of the market Tuesday that its fiscal third quarter revenues grew 8 percent year over year, topping the consensus Wall Street estimate.
Get four certifications in a row! Tianlong Science and Technology E. coli and other nucleic acid kits obtained CE certification and entered the EU market!
2022-08-17
Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification.
Total:
3779
Pages:
252
First
Prev
1
..
139
140
141
142
143
144
145
..
252
Next
End